New imaging combo could sharpen brain tumor detection
NCT ID NCT07475390
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing two different imaging techniques—SPECT and PET—to see how well they can spot brain tumors called gliomas. Forty patients with primary or recurrent glioma will receive injections of two special tracers, then undergo scans to measure how much tracer is taken up by the tumor compared to normal brain tissue. The goal is to compare the accuracy of these methods for diagnosing and monitoring brain tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
99mTc-1-thio-D-glucose and 18F-Fluoroethyl-l-tyrosine (18F-FET)
What this could lead to
If successful, this could lead to better imaging techniques for detecting and monitoring brain tumors, helping doctors make more accurate diagnoses.
What could go wrong
This is a small, early-stage study with only 40 participants. It focuses on comparing imaging methods, not on treating the disease, so it may not directly improve patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA (ANY GRADE) IN THE BRAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, Tomsk Oblast, 634050, Russia